Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
Annemieke M BootGema AricetaSigne Sparre Beck-NielsenMaria Luisa BrandiKarine BriotCarmen de Lucas CollantesSandro GianniniDieter HaffnerRichard KeenElena LevtchenkoM Zulf MughalOuti MakitieOla NilssonDirk SchnabelLiana Tripto-ShkolnikM Carola ZillikensJonathan LiuAlina TudorFrancesco EmmaPublished in: Therapeutic advances in chronic disease (2024)
European Union electronic Register of Post-Authorisation Studies: EUPAS32190.
Keyphrases